Background
==========

For many patients, including cancer patients, preserving patient autonomy is a central component of the patient-centered model.[@b1-ppa-12-1659] The model focuses on active patient participation, values, and needs in order to improve the overall quality of care. It presents a shift from a paternalistic approach in clinical management, to an approach that ensures mutual decision-making between patients and physicians.[@b2-ppa-12-1659] When the patient-centered model has been implemented, studies found improvement in the quality of health care, decrease in costs, and greater satisfaction for health care providers and patients.[@b3-ppa-12-1659],[@b4-ppa-12-1659]

Levels of patient autonomy vary significantly around the world. For example, in Eastern cultures, health care providers involve the family in the decision-making process, often without the patient's consent. Indeed, some patients may know less than their family about their own diagnoses, procedures, and planned interventions.[@b5-ppa-12-1659]

In Saudi Arabia, a country with a Middle Eastern culture and a predominately Muslim population, a number of studies found that oncologists often initially disclosed cancer information to the patient's family, and that the family would then take over decision-making in terms of procedure and medical interventions. However, on the contrary, these studies also found that almost all cancer patients preferred self-disclosure of cancer as well as more active participation in medical decision-making.[@b6-ppa-12-1659]--[@b10-ppa-12-1659]

Although previous studies in Saudi Arabia examined the attitude of patients toward cancer diagnosis disclosure (CDD), there is a paucity of research exploring family perspectives toward CDD. To our knowledge, there is no study that has explored important aspects related to attitudes of patients and families toward CDD in Saudi Arabia (eg, reasons for disclosure/nondisclosure, patient reaction to CDD, and factors to accept CDD). Our study aims to fill this gap in the literature by examining the perspectives of patients and their families toward CDD, and exploring the factors that influence their attitudes.

Methods
=======

Participants and procedures
---------------------------

The present study involves a cross-sectional survey of cancer patients and their families. Convenience sampling was used. Inclusion criteria were cancer patients aged 18 or above accompanied by family member, based at the Oncology Clinic of the King Abdullah Medical City. Cancer in patients and their accompanied family members were also included in the study. At the time of surveying, the medical city housed 550 beds, providing tertiary care to patients from across Saudi Arabia, although patients were largely from the western coast of the country. All participants in the study were Muslims. Exclusion criteria were lack of capacity to consent and refusal of participation.

In total, 581 individuals (304 cancer patients and 277 family members) were involved in the study. Each individual was given information explaining the study and was asked to verbally consent to participation. Those who accepted were then interviewed by a member of the research team via direct questioning. Patients were first interviewed apart from their families in the waiting area of the oncology outpatient clinic, or in their rooms if they were in patients. Families were then subsequently interviewed by the same research member separately. Twenty-seven family members refused to participate. Reasons for nonparticipation included interruptions due to patient appointments or lack of interest.

Measurements
------------

The study involved the development of a questionnaire examining the attitudes of patients and their family members. The questionnaire was adopted from Farhat et al,[@b11-ppa-12-1659] who attempted to capture religious and social factors influencing decision-making. The questionnaire gathered information on the following: demographic information (age, sex, education level, relationship to patient, and employment status); clinical information (primary cancer type, disease stage, and awareness of cancer diagnosis); attitude toward CDD and factors influencing decision-making, which encompassed the first 16 questions based on the questionnaire from Farhat et al.[@b11-ppa-12-1659] This final point includes information pertaining to preference of CDD, reasons for disclosure and nondisclosure, knowledge about cancer, expected patient reaction when learning about diagnosis, and factors that may help in accepting cancer diagnosis.

Statistical analysis
--------------------

The study employed descriptive statistics to describe the general demographics of patients and family members. We used an unpaired Student's *t*-test or *χ*^2^ test to determine significant differences between the patient and family group. In addition, we used binary logistic regression analysis to estimate the odds ratio for three dependent variables: 1) preference of CDD, 2) preference of detailed cancer-related information, and 3) timing of CDD (before or after treatment). The significant level was set at *P*\<0.05. IBM SPSS Statistics 21.0 (IBM Corporation, Armonk, NY, USA) was used for all statistical analyses.

Results
=======

Sample characteristics
----------------------

Five hundred and eighty-one subjects participated in this study (304 patients and 277 family members). [Table 1](#t1-ppa-12-1659){ref-type="table"} shows the characteristics of the respondents. The patient group consisted of more females (*P*\<0.001), and subjects were older (*P*\<0.001), less educated (*P*\<0.001), and more unemployed (*P*\<0.001) compared to the family group. The patient group were accompanied by children more often than other types of family members (*P*\<0.001), and the majority of the patient group (86.27%) knew about the diagnosis prior to treatment.

Differences in attitudes toward CDD
-----------------------------------

Having knowledge about cancer was reported by 54.2% of the patients and 59.5% of their family members. Their sources of information were the media (26.3% and 33.7%, respectively), physicians (28.6% and 18.8%), personal experience (30.6% and 1.4%), and family experience (6.6% and 25%).

The patient group was more likely to respond that the patient should be informed about the cancer diagnosis than the family group (82.6% vs 75.3%, *P*\<0.05; [Figure 1](#f1-ppa-12-1659){ref-type="fig"}); and more likely to respond that the patient should be informed about the details of the cancer status (cancer stage, prognosis, and management) (83.6% vs 59.9%, *P*\<0.001; [Figure 1](#f1-ppa-12-1659){ref-type="fig"}). The reasons that participants gave for answering "Yes" or "No" to the questions of disclosure are detailed in [Table 2](#t2-ppa-12-1659){ref-type="table"}.

The patient group was more likely to respond that the patient should be informed about the cancer diagnosis prior to the start of treatment than the family group (72.9% vs 64%, *P*\<0.05; [Figure 1](#f1-ppa-12-1659){ref-type="fig"}). In addition, the patient group was more likely than the family to think that cancer patients can recover from cancer (87.4% vs 75.4%, *P*\<0.001). No significant differences were found between the three questions in [Figure 1](#f1-ppa-12-1659){ref-type="fig"} and different age groups (\<30, 31--50, 51--70 and \>70 years) in the patient or the family groups.

Concerning factors that could help individuals accept the cancer diagnosis, nonsignificant differences were observed between the patient and the family groups. Three factors were chosen by both groups as most important: 1) religion, 2) relationship between doctor and patient, and 3) support from family and friends ([Table 2](#t2-ppa-12-1659){ref-type="table"}). In terms of attitude after CDD, fear was most commonly selected by both patient and family groups, although it was chosen more by the family group (56.3% vs 70.4%, *P*\<0.001), while acceptance was chosen more by the patient group (38% vs 15.2%, *P*\<0.001).

Binary logistic regression analyses
-----------------------------------

This study involved binary logistic regression to explore factors that could contribute to the three questions in [Figure 1](#f1-ppa-12-1659){ref-type="fig"}. The study analyzed the following: participant group (either patient group or family group), gender, age, education level, having information about cancer, and employment status ([Table 3](#t3-ppa-12-1659){ref-type="table"}).

For Question 1 as a response variable, having information about cancer and being employed were the only two categories favoring the response variable. While for Question 2 as a response variable, being a patient in the group was the only variable with a significant association. Finally, for Question 3 as a response variable, being a patient, having information about cancer, and being employed were found to significantly predict the response variable.

Discussion
==========

Preference of cancer disclosure
-------------------------------

The results of this study confirm patient preference for CDD and related information, as has been shown in previous studies in Saudi Arabia, and around the world.[@b5-ppa-12-1659],[@b7-ppa-12-1659],[@b10-ppa-12-1659],[@b12-ppa-12-1659],[@b13-ppa-12-1659] We add to the literature one more study about the perception toward CDD of patients and their families. Despite the importance of this topic, it has only been investigated by a single recent study, from Zekri et al.[@b10-ppa-12-1659] We found that cancer patients preferred to be informed about the cancer diagnosis more than their families (82.6% vs 75.3%, *P*\<0.05). However, when both patient and family groups were asked about their preferences toward detailed information about cancer status (in terms of cancer stage, prognosis, and management), the gap between group preferences was found to be larger (83.6% vs 59.9%, *P*\<0.001).

Similarly, recent results of a Saudi study[@b10-ppa-12-1659] found that 52% of patients' family members, compared with 85% of patients (*P*\<0.001), preferred disclosure of information regarding cancer (diagnosis, possible poor outcome, chemotherapy, failure of treatment, changes in condition and outcome, serious health updates, and lack of specific anticancer treatment options), while the gap between the preferences of both groups was found to be closer when asked about disclosure preference for cancer diagnosis only (patient: 87% vs family: 68%, *P*\<0.001). This gap in preferences may have reflected how much knowledge about the cancer prognosis was provided to cancer patients and their family members in the cancer journey. Moreover, studies from Western and non-Western countries[@b14-ppa-12-1659],[@b15-ppa-12-1659] found approximately 80% of family members and only 30%--60% of patients were aware when the cancer had become terminal.[@b16-ppa-12-1659] In conclusion, this may indicate the tendency of family members to prefer disclosure of scarce cancer-related information to cancer patients.

Reasons for disclosure and nondisclosure
----------------------------------------

Part of the explanation of the family group preference of scarce information to the patient, in our study, can also be contributed to the reasons that they chose for nondisclosure. Among the reasons for nondisclosure, preventing a negative effect on the patient (77%) emerged as the most popular. This may reflect the intention of family members to protect cancer patients from psychological distress, which is thought to be the most important factor for preference of nondisclosure.[@b17-ppa-12-1659],[@b18-ppa-12-1659] A recent study completed in Egypt, a country with a similar culture to Saudi Arabia,[@b19-ppa-12-1659] found that family members who preferred a nondisclosure of cancer diagnosis to patients also responded that they would prefer not to know their own cancer diagnosis in the event that they developed cancer. This may reflect their own fear of psychological distress.

The three reasons for cancer disclosure in our study were as follows: helping patient's treatment, organizing their lives, and avoiding living under an illusion. These reasons were selected by both the patients and their family members more than any other reasons. In essence, these are among the main benefits of CDD to patients; taken collectively, they improve the patient's quality of life. A recent study indicated that patients who were informed about their cancer treatment were found to have better health competence, a greater sense of control over cancer, and improved symptom management.[@b20-ppa-12-1659] On the contrary, noninformed patients were found to have higher levels of anxiety and irritability than informed patients.[@b21-ppa-12-1659]

Important factors in acceptance of cancer disclosure
----------------------------------------------------

In response to questions concerning the factors that help patients and family members accept cancer conditions, religion (91%), relationship between doctor and patient (patient: 87.4% vs family: 89.2%), and support from family and friends (patient: 85.1% vs family: 90.5%) were the three factors chosen more than any others. Religion is a fundamental influence for the decision-making of Muslims. A recent study[@b22-ppa-12-1659] found that 74.3% of Muslim patients with colorectal cancer responded that their entire approach to life was based on religious beliefs. In another study, 90% of medical patients reported that religious beliefs helped them to cope with their illness.[@b23-ppa-12-1659] This religious background may have led 91% of our participants to select religion as a key factor for accepting a cancer diagnosis. However, further exploration of religion as a contributing factor in acknowledging cancer diagnosis is warranted.

The result that the relationship between doctor and patient is one of the most important factors in accepting a cancer diagnosis aligns with recent studies that have found an association between doctor--patient communication and cancer patient outcomes, especially satisfaction, psychological morbidity, and understanding.[@b24-ppa-12-1659] In regard to the support of family and friends, the Middle Eastern cultural and religious values of participants encourage them to provide support to their relatives in need.[@b7-ppa-12-1659]

Patient reaction to disclosure and cure rate
--------------------------------------------

Concerning patient reaction to cancer disclosure, negative emotions (denial, fear, anger, and sadness) were expected by families to emerge, more than what patients expected themselves. This is particularly true for fear, as our study found statistical differences between the two groups (patients: 56.3% vs families: 70.4%, *P*\<0.001). Indeed, many studies have found cancer to be the most feared disease.[@b25-ppa-12-1659],[@b26-ppa-12-1659]

A recent study in Lebanon[@b11-ppa-12-1659] found that both patient and family groups expected fear (33%) as the first reaction of the patient to cancer disclosure with nonsignificant differences. The study found fear to be the most difficult feeling a cancer patient may have to experience (63% of all participants).[@b11-ppa-12-1659] On the other hand, acceptance, a positive emotion was expected by patients more than their families (38% vs 15.2%, *P*\<0.001).

In addition to this, family members not only expected patients to show negative emotions but also they were more negative in terms of recovery rate (families: 75.4% vs patients: 87.4%, *P*\<0.001). These findings may indicate that the family is more pessimistic than the patient group toward the cancer treatment, or that the patient group is more hopeful and optimistic than the family.

Study limitations
-----------------

Our study had several limitations. First, we used convenient sampling. Using probability sampling method would have been a better method, especially if the patients and family members were matched based on time since cancer diagnosis, extent of cancer knowledge, or relation to patient. Second, the family members accompanying the patients might not have been representative of all family members. Finally, participants were recruited from only one hospital.

Clinical implications
---------------------

This study indicates the preference of families toward nondisclosure attitudes for cancer diagnosis.[@b5-ppa-12-1659],[@b10-ppa-12-1659],[@b12-ppa-12-1659] It also shows the tendency of families to disclose only limited cancer information as the disease progresses. Therefore, physicians need to be vigilant in discerning how much information cancer patients actually possess throughout the treatment process.

To ease the nondisclosure attitude of family members of cancer patients in non-Western cultures, we suggest addressing any fears that families may have on causing psychological distress on the patients. As we mentioned earlier, this reason is thought to be the most important factor for nondisclosure,[@b18-ppa-12-1659] and was the most popular selection among other reasons in our sample. This can be facilitated by utilizing physician--patient communication protocols described in the literature -- one of the most renowned is the SPIKES protocol[@b27-ppa-12-1659] -- as well as applying suggested approaches for culturally competent communication.[@b28-ppa-12-1659],[@b29-ppa-12-1659] Finally, we recommend educating families about the benefits of well-informed patients, which include, among other things, better health competence, greater sense of control over cancer, and improved symptom management.[@b20-ppa-12-1659]

Conclusion
==========

This study provides insight into the attitude of cancer patients and their families toward cancer diagnosis in a sample of participants from Saudi Arabia. We found that most patients preferred full disclosure of all details of their cancer treatment, while families were more inclined to providing scarce information. Fear and pessimistic expectations toward cancer disclosure and its management characterized the experience of family members, but was less common among patients. Ultimately, we proposed that the physician--patient relationship and family support play a crucial role in facilitating CDD and its related information. The findings of this study, concerning patient and family preferences and attitudes, can be utilized to provide more effective cancer treatment.
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###### 

The characteristics of the subjects

  Characteristics                  Patient group, N=304   Family group, N=277   *P* -value
  -------------------------------- ---------------------- --------------------- ------------
  Age                                                                           \<0.001
   Mean                            48.3                   36.51                 
   SD                              15.3                   12.5                  
  Gender                                                                        \<0.001
   Male                            114 (37.6%)            129 (53.1%)           
   Female                          189 (62.4%)            114 (46.9%)           
  Education                                                                     \<0.001
   Did not complete high school    152 (50.2%)            59 (24.3%)            
   Completed high school           151 (49.8%)            184 (75.7%)           
  Employment                                                                    \<0.001
   Employed                        63 (20.8%)             108 (44.4%)           
   Unemployed                      240 (79.2%)            135 (55.6%)           
  Relation to patient                                                           \<0.001
   Father                          --                     10 (5.6%)             
   Mother                          --                     22 (12.4%)            
   Husband or wife                 --                     32 (18.1%)            
   Son or daughter                 --                     74 (41.8%)            
   Brother or sister               --                     21 (11.9%)            
   Other                           --                     18 (10.2%)            
  Time of knowing the diagnosis                                                 
   Before treatment                245 (86.27%)           --                    
   During treatment                27 (9.51%)             --                    
   After treatment                 12 (4.23%)             --                    
  Type of cancer                                                                
   Breast cancer                   68 (22.4%)             --                    
   Lymphoid cancer                 56 (18.4%)             --                    
   Gastrointestinal cancer         64 (21.1%)             --                    
   Genitourinary cancer            31 (10.2%)             --                    
   Lung cancer                     16 (5.26%)             --                    
   Central nervous system cancer   9 (2.96%)              --                    
   Thyroid cancer                  7 (2.30%)              --                    
   Other types                     32 (10.5%)             --                    
   Patient does not know           21 (6.91%)             --                    
  Stage of cancer                                                               
   Metastasized                    57 (19.86%)            --                    
   Not metastasized                163 (56.79%)           --                    
   Patient does not know           67 (23.34%)            --                    

###### 

Differences in attitudes toward disclosure of cancer diagnosis

  Factors that help patient in accepting cancer diagnosis   Patient n=304           Family member n=277           *P*-value
  --------------------------------------------------------- ----------------------- ----------------------------- -------------------------------------------------
   Support from family and friends                          257 (85.1%)             209 (90.5%)                   0.06
   Relationship between the doctor and the patient          264 (87.4%)             206 (89.2%)                   0.53
   Relationship between the nursing staff and the patient   220 (72.8%)             166 (71.9%)                   0.80
   Religion                                                 277 (91.7%)             211 (91.3%)                   0.87
   Quality of health care                                   230 (76.2%)             182 (78.8%)                   0.47
   Location of treatment                                    210 (69.5%)             167 (72.3%)                   0.48
   Knowing that the patient will be cured                   219 (72.5%)             177 (76.6%)                   0.28
                                                                                                                  
  **Reasons for cancer disclosure**                         **Patient n**=**241**   **Family member n**=**170**   
                                                                                                                  
   To better organize remaining life                        169 (70.1%)             121 (71.1%)                   0.81
   To help in treatment course                              181 (75.1%)             132 (77.6%)                   0.55
   To improve family relationships                          59 (24.4%)              55 (32.3%)                    0.79
   To avoid living under an illusion                        100 (41.4%)             83 (48.8%)                    0.14
   To get several medical advices                           58 (24%)                52 (30.5%)                    0.14
                                                                                                                  
  **Reasons for cancer nondisclosure**                      **Patient n**=**55**    **Family member n**=**48**    
                                                                                                                  
   To prevent a negative effect on the patient              37 (67.2%)              37 (77%)                      0.59
   To avoid change in daily life                            9 (16.3%)               11 (22.9%)                    0.56
   To avoid pity from others                                22 (40%)                22 (45.8%)                    0.31
   No treatment for cancer                                  3 (5.4%)                8 (16.6%)                     0.10
  **What is the possibility to recover from cancer?**                                                             
   \<50%                                                    37 (12.6%)              56 (24.6%)                    0.00[a](#tfn1-ppa-12-1659){ref-type="table-fn"}
   \>50%                                                    256 (87.4%)             172 (75.4%)                   
  **Patient's reaction to disclosure of cancer**                                                                  
   Denial                                                   12 (4%)                 14 (6%)                       0.27
   Fear                                                     169 (56.3%)             162 (70.4%)                   0.00[a](#tfn1-ppa-12-1659){ref-type="table-fn"}
   Anger                                                    10 (3.3%)               10 (4.5%)                     0.54
   Confusion                                                35 (11.6%)              38 (16.5%)                    0.10
   Acceptance                                               114 (38%)               35 (15.2%)                    0.00[a](#tfn1-ppa-12-1659){ref-type="table-fn"}
   Sadness                                                  72 (24%)                65 (28.2%)                    0.26

**Note:**

*P*\<0.001.

###### 

Binary logistic regression analysis predicting disclosure of cancer

  Variable                               Do you think a patient should be informed about cancer diagnosis? (yes)   Do you think a patient should be given all the details of his cancer status? (yes)   When do you think a patient should be informed about cancer? (before treatment)                                                               
  -------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------ --------------------------------------------------------------------------------- ------------ ---------------------------------------------- ------------
  Group                                                                                                                                                                                                                                                                                                                                               
   Family                                1                                                                                                                                                              1[a](#tfn2-ppa-12-1659){ref-type="table-fn"}                                                   1[b](#tfn3-ppa-12-1659){ref-type="table-fn"}   
   Patient                               1.38                                                                      0.88--2.15                                                                           3.26                                                                              2.11--5.05   1.59                                           1.05--2.41
  Gender                                                                                                                                                                                                                                                                                                                                              
   Female                                1                                                                                                                                                              1                                                                                              1                                              
   Male                                  0.63                                                                      0.39--1.00                                                                           0.85                                                                              0.54--1.36   0.69                                           0.44--1.07
  Age                                                                                                                                                                                                                                                                                                                                                 
   50 and older                          1                                                                                                                                                              1                                                                                              1                                              
   Younger than 50                       1.42                                                                      0.85--2.38                                                                           1.46                                                                              0.88--2.42   1.26                                           0.78--2.01
  Education                                                                                                                                                                                                                                                                                                                                           
   Lower than high school                1                                                                                                                                                              1                                                                                              1                                              
   Higher than high school               1.23                                                                      0.71--2.11                                                                           1.20                                                                              0.70--2.04   1.21                                           0.73--2.01
  Cancer information                                                                                                                                                                                                                                                                                                                                  
   Not having information about cancer   1[b](#tfn3-ppa-12-1659){ref-type="table-fn"}                                                                                                                   1                                                                                              1[a](#tfn2-ppa-12-1659){ref-type="table-fn"}   
   Having information about cancer       1.80                                                                      1.15--2.84                                                                           1.48                                                                              0.95--2.29   1.93                                           1.27--2.94
  Employment                                                                                                                                                                                                                                                                                                                                          
   Not employed                          1[b](#tfn3-ppa-12-1659){ref-type="table-fn"}                                                                                                                   1                                                                                              1[a](#tfn2-ppa-12-1659){ref-type="table-fn"}   
   Employed                              1.77                                                                      1.00--2.82                                                                           1.64                                                                              0.98--2.76   2.08                                           1.25--3.44

**Notes:**

*P*\<0.001;

*P*\<0.05.

**Abbreviations:** CI, confidence interval; OR, odds ratio.
